|
ANLN expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.22710000008908E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.31049999996247E-06 |
| Normal-vs-Stage2 |
1.625840E-01 |
| Normal-vs-Stage3 |
8.45420000000763E-05 |
| Normal-vs-Stage4 |
1.575840E-04 |
| Stage1-vs-Stage2 |
1.408230E-02 |
| Stage1-vs-Stage3 |
8.048400E-01 |
| Stage1-vs-Stage4 |
1.574410E-01 |
| Stage2-vs-Stage3 |
1.414350E-02 |
| Stage2-vs-Stage4 |
4.400100E-03 |
| Stage3-vs-Stage4 |
2.240400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.90899999936201E-08 |
| Normal-vs-AfricanAmerican |
3.080400E-02 |
| Normal-vs-Asian |
8.978500E-04 |
| Caucasian-vs-AfricanAmerican |
5.880400E-01 |
| Caucasian-vs-Asian |
4.553600E-01 |
| AfricanAmerican-vs-Asian |
9.397600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.60599999996258E-06 |
| Normal-vs-Female |
2.22029999996654E-06 |
| Male-vs-Female |
4.924600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.68400000294989E-08 |
| Normal-vs-Age(41-60Yrs) |
3.975500E-03 |
| Normal-vs-Age(61-80Yrs) |
1.024570E-03 |
| Normal-vs-Age(81-100Yrs) |
2.451800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.940110E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.841790E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.732190E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.121000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.002500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.553610E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.486600E-01 |
| Classical-VS-Follicular |
1.69908531688634E-12 |
| Classical-VS-Other |
4.486600E-01 |
| Classical-VS-Normal |
5.26059995564765E-09 |
| Tall-VS-Follicular |
7.61599999999918E-05 |
| Tall-VS-Other |
2.451200E-01 |
| Tall-VS-Normal |
8.28870000000315E-05 |
| Follicular-VS-Other |
8.824000E-02 |
| Follicular-VS-Normal |
7.843000E-01 |
| Other-VS-Normal |
1.232380E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.464300E-03 |
| Normal-vs-N1 |
5.753300E-04 |
| N0-vs-N1 |
1.081370E-01 |
|
|
